Patrys Ltd
PAB
Company Profile
Business description
Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.
Contact
Level 4, 100 Albert Road
South Melbourne
Melbourne VIC 3205
AUST: +61 396703273
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
23
Stocks News & Analysis
stocks
Any benefit from acquisition of ASX listed company’s business units?
Private equity strikes again but it is difficult to conclude if shareholders are winners from the deal.
stocks
3 ASX shares to avoid
These shares have surged in price in the last year but are significantly overvalued according to our analysts.
stocks
How to find companies that can grow forever
If you want to find companies with a long growth runway, try looking for these seven attributes.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,035.60 | 41.10 | -0.51% |
| CAC 40 | 8,131.41 | 55.73 | 0.69% |
| DAX 40 | 18,498.38 | 68.33 | 0.37% |
| Dow JONES (US) | 39,056.39 | 172.13 | 0.44% |
| FTSE 100 | 8,354.05 | 40.38 | 0.49% |
| HKSE | 18,313.86 | 165.51 | -0.90% |
| NASDAQ | 16,302.76 | 29.80 | -0.18% |
| Nikkei 225 | 38,262.33 | 59.96 | 0.16% |
| NZX 50 Index | 11,728.85 | 54.04 | -0.46% |
| S&P 500 | 5,187.67 | 0.03 | -0.00% |
| S&P/ASX 200 | 7,762.60 | 41.90 | -0.54% |
| SSE Composite Index | 3,128.48 | 19.26 | -0.61% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Imugene Ltd IMU | 0.07 | 0.00 | -5.33% |
| Sayona Mining Ltd SYA | 0.04 | 0.00 | 0.00% |
| Westpac Banking Corp WBC | 26.54 | 1.35 | -4.84% |
| Cleanaway Waste Management Ltd CWY | 2.69 | 0.04 | -1.29% |
| Strike Energy Ltd STX | 0.24 | 0.02 | 6.82% |
| Botanix Pharmaceuticals Ltd BOT | 0.28 | 0.01 | -3.45% |
| Mesoblast Ltd MSB | 1.09 | 0.04 | -3.54% |
| Red 5 Ltd RED | 0.45 | 0.01 | -1.11% |
| Carnarvon Energy Ltd CVN | 0.21 | 0.01 | 5.13% |
| Pilbara Minerals Ltd PLS | 4.09 | 0.09 | -2.15% |